-
公开(公告)号：US20130078323A1
公开(公告)日：2013-03-28
申请号：US13378932
申请日：2009-06-16
申请人： Sarang Bani , Anjali Pandey , Kiranjeet Kour , Prashant Singh Chauhan , Balkrishan Chandan , Neelam Sharma , Kuldeep Singh , Surrinder Koul , Bishan Dutt Gupta , Payarelal Sangwan , Devinder Kumar Gupta , Shankar Lal , Rajendran Marnickavasagar
发明人： Sarang Bani , Anjali Pandey , Kiranjeet Kour , Prashant Singh Chauhan , Balkrishan Chandan , Neelam Sharma , Kuldeep Singh , Surrinder Koul , Bishan Dutt Gupta , Payarelal Sangwan , Devinder Kumar Gupta , Shankar Lal , Rajendran Marnickavasagar
IPC分类号： A61K36/185
CPC分类号： A61K36/185
摘要： The present invention provides a process of extracting the leaves of Labisia pumila with water into a free flowing powder using accelerated solvent system and drying. The invention also relates to the immunopotentiating effects of the extract against stress. The extract has effects on fatigue, hypoxia time, potentiation of swimming endurance, bod weight, weight of the thymus and spleen and levels of CD244+ NK cells, CD4+ and CD8+ T cells, expression of ThI cytokines IL-2 and IFN-gamma, corticosterone, glutathione, alanine aminotransferase and lipid peroxidation levels.
摘要翻译： 本发明提供了一种使用加速溶剂体系和干燥将水分提取成自由流动粉末的Labisia pumila的叶子的方法。 本发明还涉及提取物抗压力的免疫增强作用。 提取物对疲劳，缺氧时间，游泳耐力的增强，体重，胸腺和脾的重量以及CD244 + NK细胞，CD4 +和CD8 + T细胞的水平，Th1细胞因子IL-2和IFN-γ的表达，皮质酮的影响 ，谷胱甘肽，丙氨酸氨基转移酶和脂质过氧化水平。
-
公开(公告)号：US20100303933A1
公开(公告)日：2010-12-02
申请号：US12743179
申请日：2007-11-15
申请人： Ghulam Nabi Qazi , Sarang Bani , Anpurna Kaull , Anjali Pandey , Kiranjeet Kour , Surrinder Koul , Bishan Dutt Gupta , Pyrelal Sangwan , Ravinder Kumar Raina , Rajendran Manickavasagar
发明人： Ghulam Nabi Qazi , Sarang Bani , Anpurna Kaull , Anjali Pandey , Kiranjeet Kour , Surrinder Koul , Bishan Dutt Gupta , Pyrelal Sangwan , Ravinder Kumar Raina , Rajendran Manickavasagar
CPC分类号： A61K36/185
摘要： The present invention relates to an immunopotentiating composition and to a composition accelerating the production of interferon-[gamma]. More particularly to a process for preparation of water-soluble Labisia pumila extract and the use of said extract in a pharmaceutical preparation.
摘要翻译： 本发明涉及免疫增强组合物和加速干扰素-γ生成的组合物。 更具体地涉及制备水溶性Labisia pumila提取物的方法和所述提取物在药物制剂中的用途。
-
公开(公告)号：US11744807B2
公开(公告)日：2023-09-05
申请号：US17151172
申请日：2021-01-17
IPC分类号： A61K31/122 , A61P11/00 , A61K31/09 , A61K47/10 , A61K36/9066
CPC分类号： A61K31/122 , A61K31/09 , A61K36/9066 , A61K47/10 , A61P11/00
摘要： The present invention discloses a method for therapeutic management of pulmonary fibrosis in mammals using a composition comprising iso-garcinol or octahydrocurcumin or a combination of iso-garcinol and octahydrocurcumin. The composition is very suitable for treating pulmonary fibrosis due to viral infections, specifically COVID 19 and for improving lung function during prognosis.
-
公开(公告)号：US20230201134A1
公开(公告)日：2023-06-29
申请号：US17564490
申请日：2021-12-29
IPC分类号： A61K31/12 , A61K31/585 , A61P25/00
CPC分类号： A61K31/12 , A61K31/585 , A61P25/00
摘要： The invention discloses a composition and method for therapeutically managing a demyelinated disorder through remyelination. The invention includes a composition comprising Withaferin A and Bisdemethoxycurcumin (BDMC), and a pharmaceutically or nutraceutically acceptable excipients, which can be effectively formulated as tablets and capsules. The invention also covers use of composition for effectively managing a demyelinated disorder through remyelination.
-
公开(公告)号：US20230404969A1
公开(公告)日：2023-12-21
申请号：US17944762
申请日：2022-09-14
摘要： The disclosed invention relates to a method comprising composition for effective management of peritonitis in a subject. The invention also discloses a method comprising composition for preventing peritonitis mediated multi organ dysfunction and management of inflammation in a subject. The composition disclosed essentially consists of Witharione.
-
公开(公告)号：US20210220290A1
公开(公告)日：2021-07-22
申请号：US17151121
申请日：2021-01-16
摘要： The invention discloses a composition comprising not less than 20% w/w bisdemethoxycurcumin for regeneration of alveolar cells damaged in emphysematous conditions and for the therapeutic management of chronic obstructive pulmonary disease and acute respiratory distress syndrome. The composition further comprises 10-35% w/w demethoxycurcumin and 10-45% w/w curcumin. The composition is very suitable for treating COPD and ARDS due to viral infections, specifically COVID 19 and for improving lung function during prognosis.
-
7.发明授权Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof 有权组合物，其包含鞘氨醇蛋白A和柔霉素B及其抗脂肪生成/抗肥胖潜力公开(公告)号：US09387193B2
公开(公告)日：2016-07-12
申请号：US13944634
申请日：2013-07-17
申请人： Muhammed Majeed , Kalyanam Nagabhushanam , Douglas Kalman , Beena Bhat , Priti Vaidyanathan , Sarang Bani , Anjali Pandey
发明人： Muhammed Majeed , Kalyanam Nagabhushanam , Douglas Kalman , Beena Bhat , Priti Vaidyanathan , Sarang Bani , Anjali Pandey
IPC分类号： A61K31/343 , A61K36/8905
CPC分类号： A61K31/343 , A61K36/8905
摘要： Disclosed is a composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof. Also disclosed are methods of inhibiting adipogenesis using a composition comprising scirpusin A and scirpusin B. The present invention also disclosed methods of therapeutically managing obesity in mammals using a composition comprising scirpusin A and scirpusin B. Still further, the present invention also relates to a method of obtaining compositions comprising A. scirpusin A and scirpusin B and B. piceatannol and its dimers scirpusin A and scirpusin B through bioactivity guided fractionation of the rhizomes of Cyperus rotundus.
摘要翻译： 本发明公开了一种组合物，其中含有柔霉素A和柔霉素B及其抗肥胖潜力。 还公开了使用包含灵敏蛋白A和柔红霉素B的组合物来抑制脂肪生成的方法。本发明还公开了使用包含巩螺素A和柔红霉素B的组合物来治疗哺乳动物肥胖的方法。此外，本发明还涉及一种方法 通过生物活性引导分离莎草莎草根茎，获得包含A.Scirpusin A和Scirpusin B和B.piceatannol及其二聚体scirpusin A和scirpusin B的组合物。
-
公开(公告)号：US20110218172A1
公开(公告)日：2011-09-08
申请号：US12768871
申请日：2010-04-28
申请人： Muhammed Majeed , Anjali Pandey , Sarang Bani , Beena Bhat
发明人： Muhammed Majeed , Anjali Pandey , Sarang Bani , Beena Bhat
IPC分类号： A61K31/715 , A61P29/00
CPC分类号： A61K31/715
摘要： The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide faction obtained from Boswellia species at specific concentrations showing enhancement in their activity as compared to boswellic acid fraction and the polysaccharide fraction alone. The invention further comprises use of polysaccharide fraction individually or in combination with boswellic acid fraction for inhibition of PGE2.
摘要翻译： 本发明提供用于下调促炎症标记物的组合物。 组合物包含从乳香属物种获得的特异性浓度的乳香酸级分和多糖类，其显示出与乳香酸级分和单独的多糖级分相比其活性增强。 本发明还包括单独使用多糖级分或与乳香酸级分组合用于抑制PGE2。
-
公开(公告)号：US20200268822A1
公开(公告)日：2020-08-27
申请号：US16386376
申请日：2019-04-17
摘要： The present invention discloses a composition for the therapeutic management of male sexual dysfunction and related disorders. Specifically, the invention discloses a composition comprising 60-65% w/w Withania somnifera extract, 12-18% w/w Mucana pruriens extract, 5-10% w/w Coleus forskolii extract, 12-18% w/w Kaempferia parviflora extract, 0.1-2% w/w Piper nigrum extract, for use as an aphrodisiac.
-
公开(公告)号：US20170128410A1
公开(公告)日：2017-05-11
申请号：US14936830
申请日：2015-11-10
IPC分类号： A61K31/352 , C12N5/077 , G01N33/50
CPC分类号： A61K31/352 , A61K35/35 , C12N5/0653 , C12N2501/01 , C12N2506/13 , G01N33/5044 , G01N2333/51 , G01N2333/515
摘要： Disclosed is a method of achieving optimal mammalian energy balance using forskolin on a particular physiological and developmental stage of the mammalian cellular system.
-
-
-
-
-
-
-
-
-
搜索结果
28 条记录 (耗时 0.033 秒)
